Three core technology platforms
Covering the entire IVD industry value chain
Continue to develop innovative IVD prouducts

U-GEN is a precision diagnostics company with vertical integration of upstream to downstream IVD industry for the provision of precision medical care, bringing together biotech and medical experts from across the Greater China Region. We leverage three advanced technology platforms for the research and development of IVD products addressing health-threatening diseases, particularly for the Chinese population. Our porfolio includes commercialized molecular diagnostic products targeting early-stage tumor screening and major chronic diseases. We are dedicated to establishing the company as a pioneer in the field of precision diagnostics in Asia.

Technology Platform

U-GEN’s proprietary platforms aim to provide users with more flexible and efficient solutions. We have established capabilities across first- to third-generation gene sequencing, with a strong emphasis on advancing multiplex diagnostic technologies. By leveraging our successful international certification experience in China, the United States, and the European Union, we conduct clinical validation to accelerate product launches and expand our global market reach.

Genetic Analysis Platform

Total solution for multiple NAT detection, specializing in HLA gene typing.

Tumor Early Screening Platform

Early-stage tumor screening, precision medical care.

Multiplex Magnetic Bead Platform

EdgeCode® Multiplex Magnetic Beads for multiplex detection in biomedical diagnostics.

Product Development Strategy

Global health policy trends focus on improving early cancer screening to reduce healthcare costs and lower cancer mortality. U-GEN actively integrates multiple innovative technologies and is committed to developing high-value early detection reagents. We have established a comprehensive approach across the “early assessment, early screening, and early diagnosis” continuum, providing a full range of genetic testing solutions. By analyzing hereditary gene sequences, epigenetic expression, and acquired genetic mutations, we support cancer screening and diagnosis.

Early Assessment

Risk Assessment
Genetic Inheritance

HLA Typing
Susceptibility Gene

Early Screening

Pan-cancer Screening
Epigenetic Expression

Cancer 5-Panel
Cancer 10-Panel

Early Diagnosis

Single Cancer Detection
Acquired Mutations

Urinary Tract
GI Tract